![Charles Link](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Charles Link
Gründer bei
Syncromune, Inc.
Profil
Charles J.
Link was the founder of NewLink Genetics Corp.
(1999), serving as Chairman, Chief Executive & Scientific Officer from 2003 to 2019; Central Iowa Hospital Corp.
(1995), serving as Director from 1995 to 2003; and Syncromune, Inc. (2020), serving as Executive Chairman.
Current jobs include Director at NovaScan, Inc. (2020 - present), Director at ImmunSYS, Inc. (present), and Director at Viewpoint Molecular Targeting, Inc. (2021 - present).
Former jobs include Chairman & Chief Executive Officer at BioProtection Systems Corp.
(2005 - 2009), Independent Director at QSAM Biosciences, Inc. (2021 - 2024), and Chief Executive & Scientific Officer at Lumos Pharma, Inc. Education includes a doctorate from Stanford University School of Medicine.
Aktive Positionen von Charles Link
| Unternehmen | Position | Beginn |
|---|---|---|
ImmunSYS, Inc.
 ImmunSYS, Inc. Pharmaceuticals: MajorHealth Technology Manufactures cancer immunotherapy products | Direktor/Vorstandsmitglied | - |
NovaScan, Inc.
 NovaScan, Inc. Medical SpecialtiesHealth Technology Manufactures cancer detection instrument | Direktor/Vorstandsmitglied | 01.01.2020 |
Viewpoint Molecular Targeting, Inc.
 Viewpoint Molecular Targeting, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Direktor/Vorstandsmitglied | 18.05.2021 |
Syncromune, Inc.
 Syncromune, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops intratumoral immunotherapy platform for treating metastatic solid tumors | Gründer | 01.01.2020 |
Ehemalige bekannte Positionen von Charles Link
| Unternehmen | Position | Ende |
|---|---|---|
QSAM Biosciences, Inc.
 QSAM Biosciences, Inc. Chemicals: AgriculturalProcess Industries Manufactures compost | Direktor/Vorstandsmitglied | 02.05.2024 |
| LUMOS PHARMA, INC. | Vorstandsvorsitzender | 03.08.2019 |
| LUMOS PHARMA, INC. | Vorstandsvorsitzender | 03.08.2019 |
BioProtection Systems Corp.
 BioProtection Systems Corp. BiotechnologyHealth Technology Manufacturers biological products | Vorsitzender | 01.01.2009 |
Central Iowa Hospital Corp. | Gründer | 01.01.2003 |
Ausbildung von Charles Link
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
22
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
NewLink Genetics Corp.
 NewLink Genetics Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops, and commercializes novel immunotherapeutic products for treatment of cancer | Health Technology |
BioProtection Systems Corp.
BioProtection Systems Corp. BiotechnologyHealth Technology Manufacturers biological products | Health Technology |
Central Iowa Hospital Corp. | |
Stanford University School of Medicine
 Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
QSAM Biosciences, Inc.
QSAM Biosciences, Inc. Chemicals: AgriculturalProcess Industries Manufactures compost | Process Industries |
NovaScan, Inc.
NovaScan, Inc. Medical SpecialtiesHealth Technology Manufactures cancer detection instrument | Health Technology |
ImmunSYS, Inc.
ImmunSYS, Inc. Pharmaceuticals: MajorHealth Technology Manufactures cancer immunotherapy products | Health Technology |
Viewpoint Molecular Targeting, Inc.
Viewpoint Molecular Targeting, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
Lumos Pharma, Inc.
 Lumos Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops and markets therapeutics for rare diseases | Health Technology |
Syncromune, Inc.
Syncromune, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops intratumoral immunotherapy platform for treating metastatic solid tumors | Health Technology |
